Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria R. Farcet
Observed names:
M R Farcet,
Maria Farcet,
Maria R Farcet
Institution:
Takeda (Austria)
Observed institutions:
Baxter (Austria),
Takeda (Austria)
ORCID:
0000-0002-2335-8609
Observed ORCID:
0000-0002-2335-8609
OpenAlex ID:
A5008670272
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays
2020
·
Lisa Weidner
, Simon Gänsdorfer
, et al.
·
Journal of Clinical Virology
·
132
PDF
Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing
2010
·
Andreas Berting
, Maria R. Farcet
, et al.
·
Biotechnology and Bioengineering
·
107
PDF
B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19
2021
·
Andreas Zollner
, Christina Watschinger
, et al.
·
EBioMedicine
·
80
PDF
No SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected Before the 2020 Pandemic
2020
·
Julia Schwaiger
, Michael Karbiener
, et al.
·
The Journal of Infectious Diseases
·
59
PDF
Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Intravenous Immunoglobulins Produced From Plasma Collected During the 2020 Pandemic
2021
·
Maria R Farcet
, Michael Karbiener
, et al.
·
The Journal of Infectious Diseases
·
46
PDF
Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes
2015
·
Maria R. Farcet
, Cornelia Lackner
, et al.
·
Transfusion
·
44
Human IgG Subclasses:In VitroNeutralization of andIn VivoProtection against West Nile Virus
2010
·
Yvonne Hofmeister
, Christina B. Planitzer
, et al.
·
Journal of Virology
·
44
Cytomegalovirus Neutralization by Hyperimmune and Standard Intravenous Immunoglobulin Preparations
2011
·
Christina B. Planitzer
, Marcus D. Saemann
, et al.
·
Transplantation
·
41
Increasing West Nile virus antibody titres in central European plasma donors from 2006 to 2010
2011
·
P O Rabel
, C B Planitzer
, et al.
·
Eurosurveillance
·
37
PDF
Hepatitis A virus antibodies in immunoglobulin preparations
2009
·
Maria R. Farcet
, Christina B. Planitzer
, et al.
·
Journal of Allergy and Clinical Immunology
·
34
Chikungunya virus and the safety of plasma products
2012
·
Sandra M. Leydold
, Maria R. Farcet
, et al.
·
Transfusion
·
33
Parvovirus B19 rebound outbreak 2024 and implications for blood‐ and plasma‐product safety
2024
·
Maria R. Farcet
, Michael Karbiener
, et al.
·
Transfusion
·
32
PDF
Characterization of 100 sequential SARS‐CoV‐2 convalescent plasma donations
2020
·
Christof Jungbauer
, Lukas Weseslindtner
, et al.
·
Transfusion
·
31
Highly Potent SARS-CoV-2 Neutralization by Intravenous Immunoglobulins manufactured from Post-COVID-19 and COVID-19-Vaccinated Plasma Donations
2021
·
Michael Karbiener
, Maria R Farcet
, et al.
·
The Journal of Infectious Diseases
·
29
PDF
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
2021
·
Angelika Wagner
, Angela Guzek
, et al.
·
Communications Medicine
·
28
PDF
Tick-Borne Encephalitis Virus-Neutralizing Antibodies in Different Immunoglobulin Preparations
2012
·
Philip O. Rabel
, Christina B. Planitzer
, et al.
·
Clinical and Vaccine Immunology
·
27
SARS-CoV-2 and the safety margins of cell-based biological medicinal products
2020
·
Jens Modrof
, Astrid Kerschbaum
, et al.
·
Biologicals
·
22
PDF
Calibrated comparison of SARS-CoV-2 neutralizing antibody levels in response to protein-, mRNA-, and vector-based COVID-19 vaccines
2022
·
Michael Karbiener
, Maria R. Farcet
, et al.
·
npj Vaccines
·
20
PDF
Hyperimmune intravenous immunoglobulin containing high titers of pandemic H1N1 hemagglutinin and neuraminidase antibodies provides dose-dependent protection against lethal virus challenge in SCID mice
2014
·
Christine Hohenadl
, Walter Wodal
, et al.
·
Virology Journal
·
20
PDF
Inactivation of hepatitis A variants during heat treatment (pasteurization) of human serum albumin
2011
·
Maria R. Farcet
, Johanna Kindermann
, et al.
·
Transfusion
·
19
Neutralization of different echovirus serotypes by individual lots of intravenous immunoglobulin
2010
·
Christina B. Planitzer
, Maria R. Farcet
, et al.
·
Journal of Medical Virology
·
18
Omicron Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Immunoglobulin Preparations Manufactured From Plasma Collected in the United States and Europe
2022
·
Maria R Farcet
, Michael Karbiener
, et al.
·
The Journal of Infectious Diseases
·
14
PDF
Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
2017
·
Jens Modrof
, Björn Tille
, et al.
·
The Journal of Infectious Diseases
·
13
PDF
Z ika virus is not thermostable: very effective virus inactivation during heat treatment (pasteurization) of human serum albumin
2016
·
Maria R. Farcet
, Thomas R. Kreil
·
Transfusion
·
13
Longitudinal analysis of SARS‐CoV ‐2 antibodies in 8000 U.S. first‐time convalescent plasma donations
2021
·
Michael Karbiener
, Maria R. Farcet
, et al.
·
Transfusion
·
12
PDF
Show more works
View as search
Works count:
44
Citation count:
1,048
H-index:
19
I10-index:
28
Year
Topic
Type